ISRCTN14032359已完成1 期
The effect of iron deficiency on functional performance outcome measures and quality of life in exercising women
St Mary's University0 个研究点目标入组 35 人开始时间: 2016年9月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Female
入选标准
- •2. At least 18 years of age with signed written informed consent
- •3. Screening haemoglobin [Hb] = 90 g/L (9.0 g/dL) but = 130 g/L (13.0 g/dL)
- •4. Screening ferritin > 30ng/ml
- •5. Laboratory data used for determination of eligibility at the baseline visit must not be older than four weeks
- •6. Undertake at least 90 minutes of regular exercise a week
排除标准
- •Participants who, at the start of treatment, meet any of the following criteria are not eligible for the study:
- •1. Known history of acquired iron overload, or family history of haemochromatosis or thalassemia or transferrin saturation (TSAT) >50%
- •2. Known reason for anaemia (e.g. untreated B12 or folate deficiency or haemoglobinopathy)
- •3. Known hypersensitivity to Monofer iron isomaltoside 1000 or its excipients
- •4. Severe asthma or severe allergy (requiring hospitalisation within the last 12 months)
- •5. Pregnancy or lactation
- •6. Inability to fully comprehend and/or perform study procedures in the investigator’s opinion
- •7. Participant involvement in another investigational medical product trial within the previous 4 weeks, that may impact on the results of this trial
- •8. Problem preventing or impacting upon exercise test
- •9. Will be changing training during the course of this research
研究者
相似试验
招募中
2 期
Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF)diastolic heart failureNL-OMON54927Vrije Universiteit Medisch Centrum45
进行中(未招募)
1 期
Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF)Heart failure with preserved ejection fractionEUCTR2019-003461-17-NLAmsterdam UMC, location VUmc45
已完成
4 期
Effects of iron deficiency and its treatment on fibroblast growth factor 23 (FGF23) in patients treated with chronic haemodialysis therapy.ACTRN12614000548639Eastern Health Integrated Renal Service40
已完成
不适用
Defining the Functional Role of Iron in Aerobic Training and Physical PerformanceIron Deficiency Without AnemiaNCT03002090Cornell University109
已完成
不适用
Effect of Iron deficiency on skeletetal muscle metabolisme in HFpEFiron deficiency10019280diastolic heart failureNL-OMON55673Medisch Universitair Ziekenhuis Maastricht78
